Literature DB >> 11742457

The use of osteogenic protein-1 in reconstructive surgery of the hip.

S D Cook1, R L Barrack, A Shimmin, D Morgan, J P Carvajal.   

Abstract

Osteogenic proteins (OPs), also referred to as bone morphogenetic proteins (BMPs), are a family of bone matrix polypeptides that induce a sequence of cellular events that lead to the formation of new bone. This article reports the use of recombinant human OP-1 (rhOP-1, rhBMP-7) in preclinical animal models and initial human clinical experience in hip reconstructive surgery. The use of rhOP-1 in conjunction with morcellized cancellous bone and cortical strut allograft in preclinical models dramatically improved the biologic activity of the graft, resulting in greater and earlier new bone formation and graft incorporation. The clinical use of rhOP-1 in hip reconstructive procedures also resulted in greater and earlier new bone formation in the more challenging biologic environment compared with allograft bone alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742457     DOI: 10.1054/arth.2001.28363

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  10 in total

1.  The incorporation of different sorts of cancellous bone graft and the reaction of the host bone. A histomorphometric study in sheep.

Authors:  P Leniz; P Ripalda; F Forriol
Journal:  Int Orthop       Date:  2003-05-15       Impact factor: 3.075

2.  Stability of fused versus nonfused THA femoral impaction grafts.

Authors:  Anneliese D Heiner; John J Callaghan; Thomas D Brown
Journal:  J Orthop Res       Date:  2007-03       Impact factor: 3.494

Review 3.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

4.  Stability differentials for proximal vs distal fusion of total hip arthroplasty femoral impaction grafts.

Authors:  Anneliese D Heiner; John J Callaghan; Thomas D Brown
Journal:  J Arthroplasty       Date:  2008-01-24       Impact factor: 4.757

5.  A review of the treatment of pelvic discontinuity.

Authors:  M Villanueva; A Rios-Luna; J Pereiro De Lamo; H Fahandez-Saddi; M P G Böstrom
Journal:  HSS J       Date:  2008-07-15

6.  Bone morphogenic protein-2 use in revision total hip arthroplasty with acetabular defects.

Authors:  Scott R Nodzo; Keely K Boyle; Sonja Pavlesen; Sridhar Rachala
Journal:  Int Orthop       Date:  2017-11-03       Impact factor: 3.075

7.  Compressed homologous cancellous bone and bone morphogenetic protein (BMP)-7 or bone marrow accelerate healing of long-bone critical defects.

Authors:  T Djapic; V Kusec; M Jelic; S Vukicevic; M Pecina
Journal:  Int Orthop       Date:  2003-08-26       Impact factor: 3.075

Review 8.  Bone substitutes in orthopaedic surgery: from basic science to clinical practice.

Authors:  V Campana; G Milano; E Pagano; M Barba; C Cicione; G Salonna; W Lattanzi; G Logroscino
Journal:  J Mater Sci Mater Med       Date:  2014-05-28       Impact factor: 3.896

Review 9.  Supramolecular self-assembling peptides to deliver bone morphogenetic proteins for skeletal regeneration.

Authors:  Charlotte H Chen; Erin L Hsu; Samuel I Stupp
Journal:  Bone       Date:  2020-07-31       Impact factor: 4.398

10.  Abundant heterotopic bone formation following use of rhBMP-2 in the treatment of acetabular bone defects during revision hip arthroplasty.

Authors:  Alexander Arzeno; Tim Wang; James I Huddleston
Journal:  Arthroplast Today       Date:  2018-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.